Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

UK Earnings, Trading Statements Calendar - Week Ahead

Fri, 30th Jan 2015 15:05

UK Earnings, Trading Statements Calendar 
Monday, February 2 
RMFull Year Results
Tuesday, February 3 
BG GroupFull Year Results
BPFull Year Results
Ocado GroupFull Year Results
CrestonInterim Management Statement 
Aberdeen Asset ManagementQ1 Trading Statement
Alumasc GroupHalf Year Results
Low & BonarFull Year Results
St Modwen PropertyFull Year Results
TalkTalk Telecom GroupInterim Management Statement 
Wednesday, February 4 
GlaxoSmithKlineFull Year Results
Hargreaves LansdownHalf Year Results
International Consolidated Airlines GroupJanuary Traffic Statistics
SkyHalf Year Results
VictrexInterim Management Statement 
Daily Mail and General Trust Trading Statement
GW PharmaceuticalsQ1 Results
Thursday, February 5 
Fusionex International Full Year Results
McBrideInterim Results
Compass GroupInterim Management Statement
BeazleyFull Year Results
AstraZenecaFull Year Results
EasyJetJanuary Traffic Statistics
Dairy Crest GroupInterim Management Statement 
FutureInterim Management Statement 
Enterprise InnsInterim Management Statement 
GraingerInterim Management Statement 
Smith & NephewFull Year Results
Vodafone GroupInterim Management Statement 
Avanti Communications GroupHalf Year Results
Friday, February 6 
ShaftesburyAGM Statement
  
Copyright 2015 Alliance News Limited. All Rights Reserved.
  

Related Shares

More News
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was ...

7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announ...

3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.